Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.
J Clin Oncol. 2009 Nov 20;27(33):5601-6. doi: 10.1200/JCO.2009.23.2777. Epub 2009 Oct 13.
J Clin Oncol. 2009.
PMID: 19826113
Free PMC article.
Clinical Trial.
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor.
Robinson ES, Matulonis UA, Ivy P, Berlin ST, Tyburski K, Penson RT, Humphreys BD.
Robinson ES, et al. Among authors: tyburski k.
Clin J Am Soc Nephrol. 2010 Mar;5(3):477-83. doi: 10.2215/CJN.08111109. Epub 2010 Jan 7.
Clin J Am Soc Nephrol. 2010.
PMID: 20056761
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma.
Campos SM, Penson RT, Matulonis U, Horowitz NS, Whalen C, Pereira L, Tyburski K, Roche M, Szymonifka J, Berlin S.
Campos SM, et al. Among authors: tyburski k.
Gynecol Oncol. 2013 Feb;128(2):215-20. doi: 10.1016/j.ygyno.2012.07.126. Epub 2012 Aug 9.
Gynecol Oncol. 2013.
PMID: 22885865
Clinical Trial.
Item in Clipboard
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.
Liu JF, Tolaney SM, Birrer M, Fleming GF, Buss MK, Dahlberg SE, Lee H, Whalen C, Tyburski K, Winer E, Ivy P, Matulonis UA.
Liu JF, et al. Among authors: tyburski k.
Eur J Cancer. 2013 Sep;49(14):2972-8. doi: 10.1016/j.ejca.2013.05.020. Epub 2013 Jun 27.
Eur J Cancer. 2013.
PMID: 23810467
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
Campos SM, Berlin S, Krasner CN, Whalen C, Atkinson T, Meegan K, Pereira L, Tyburski K, Lou W, Lee H, Horowitz N, Penson RT.
Campos SM, et al. Among authors: tyburski k.
Cancer Chemother Pharmacol. 2022 Mar;89(3):423-430. doi: 10.1007/s00280-022-04399-2. Epub 2022 Feb 10.
Cancer Chemother Pharmacol. 2022.
PMID: 35142863
Clinical Trial.
Item in Clipboard
Cite
Cite